Study: Thiazolidinedione-statin combo may aid patients with diabetes

05/24/2011 | Renal and Urology News

A thiazolidinedione-statin combo reduced the levels of high-sensitivity C-reactive protein and improved the levels of fasting glucose and anti-inflammatory hormone adiponectin in participants compared with those who received a statin-placebo combo, experts reported at the annual meeting of the American Society of Hypertension. The findings suggest that the combination may curb systemic inflammation and onset of diabetes in high-risk patients, researchers added.

View Full Article in:

Renal and Urology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX